We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Eaton
ETN
$150B
| $57.9M | 0.14% |
781,182
+23,652
| +3% | +$1.68M |
|
152
eBay
EBAY
$51.7B
| $57.4M | 0.13% |
1,708,750
-1,992
| -0.1% | -$64.8K |
|
|
PXD
153
DELISTED
Pioneer Natural Resource Co.
PXD
| $57.3M | 0.13% |
307,504
+10,011
| +3% | +$1.86M |
|
154
S&P Global
SPGI
$128B
| $57.2M | 0.13% |
437,618
+4,123
| +1% | +$513K |
|
155
Delta Air Lines
DAL
$58.2B
| $57.2M | 0.13% |
1,243,584
+11,684
| +0.9% | +$570K |
|
156
Target
TGT
$65.5B
| $56.9M | 0.13% |
1,030,142
+20,772
| +2% | +$1.29M |
|
157
Ross Stores
ROST
$80.6B
| $56.7M | 0.13% |
860,420
+29,171
| +4% | +$1.95M |
|
158
PG&E
PCG
$40B
| $56.6M | 0.13% |
852,753
+27,479
| +3% | +$1.75M |
|
159
Boston Scientific
BSX
$69.4B
| $56.5M | 0.13% |
2,271,519
+47,510
| +2% | +$1.16M |
|
160
Exelon
EXC
$49.1B
| $56.3M | 0.13% |
2,195,106
+31,824
| +1% | +$811K |
|
161
Analog Devices
ADI
$181B
| $55.9M | 0.13% |
681,655
+152,514
| +29% | +$12M |
|
162
Aflac
AFL
$65.8B
| $55.8M | 0.13% |
1,540,508
+46,198
| +3% | +$1.64M |
|
163
Zoetis
ZTS
$32.8B
| $55.5M | 0.13% |
1,039,783
+68,601
| +7% | +$3.71M |
|
164
HP
HPQ
$25.6B
| $53.3M | 0.12% |
2,979,116
+81,475
| +3% | +$1.32M |
|
165
Aon
AON
$81.1B
| $52.6M | 0.12% |
443,568
+5,918
| +1% | +$683K |
|
166
Micron Technology
MU
$932B
| $52.5M | 0.12% |
1,817,553
+49,867
| +3% | +$1.22M |
|
167
Prologis
PLD
$138B
| $52.1M | 0.12% |
1,004,174
+59,690
| +6% | +$3.04M |
|
168
Waste Management
WM
$96.4B
| $51.4M | 0.12% |
704,430
-3,666
| -0.5% | -$262K |
|
169
Hewlett Packard
HPE
$59.7B
| $51.3M | 0.12% |
4,973,035
+135,754
| +3% | +$1.82M |
|
170
O'Reilly Automotive
ORLY
$76.4B
| $51M | 0.12% |
2,835,615
+131,220
| +5% | +$2.37M |
|
171
McKesson
MCK
$102B
| $51M | 0.12% |
343,921
-32,328
| -9% | -$4.73M |
|
172
Regeneron Pharmaceuticals
REGN
$71.9B
| $50.8M | 0.12% |
131,132
+2,824
| +2% | +$1.05M |
|
173
State Street
STT
$49.8B
| $50.8M | 0.12% |
637,533
+14,570
| +2% | +$1.16M |
|
174
Weyerhaeuser
WY
$17.6B
| $50.7M | 0.12% |
1,491,657
+77,183
| +5% | +$2.51M |
|
|
FISV
175
Fiserv Inc
FISV
$28.9B
| $50.7M | 0.12% |
878,934
+27,522
| +3% | +$1.54M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.